Stoke Therapeutics, Inc.STOKNASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P16
Within normal range
vs 3Y Ago
-6.4x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -52.31% |
| Q3 2025 | -62.50% |
| Q2 2025 | -120.51% |
| Q1 2025 | 1183.33% |
| Q4 2024 | 61.70% |
| Q3 2024 | -2.17% |
| Q2 2024 | 19.30% |
| Q1 2024 | 5.00% |
| Q4 2023 | -9.09% |
| Q3 2023 | 20.29% |
| Q2 2023 | -60.47% |
| Q1 2023 | 23.21% |
| Q4 2022 | 8.20% |
| Q3 2022 | -3.39% |
| Q2 2022 | 9.23% |
| Q1 2022 | 1.52% |
| Q4 2021 | -8.20% |
| Q3 2021 | -1.67% |
| Q2 2021 | -30.43% |
| Q1 2021 | -9.52% |
| Q4 2020 | -2.44% |
| Q3 2020 | -5.13% |
| Q2 2020 | -14.71% |
| Q1 2020 | 15.00% |
| Q4 2019 | -53.85% |
| Q3 2019 | -4.00% |
| Q2 2019 | -31.58% |
| Q1 2019 | -5.56% |
| Q4 2018 | -28.57% |
| Q3 2018 | -7.69% |
| Q2 2018 | -59.90% |
| Q1 2018 | 0.00% |